{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T12:13:57Z","timestamp":1778588037988,"version":"3.51.4"},"posted":{"date-parts":[[2022,8,16]]},"group-title":"Obstetrics and Gynecology","reference-count":39,"publisher":"openRxiv","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2022,8,18]]},"abstract":"<jats:title>Summary<\/jats:title>\n                <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>COVID-19 infection in pregnant people has previously been shown to increase the risk for poor maternal-fetal outcomes. Despite this, there has been a lag in COVID-19 vaccination in pregnant people due to concerns over the potential effects of the vaccine on maternal-fetal outcomes. Here we examine the impact of COVID-19 vaccination and booster on maternal COVID-19 breakthrough infections and birth outcomes.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This was a retrospective multicenter cohort study on the impact of COVID-19 vaccination on maternal-fetal outcomes for people that delivered (n=86,833) at Providence St. Joseph Health across Alaska, California, Montana, Oregon, New Mexico, Texas, and Washington from January 26, 2021 through July 11, 2022. Cohorts were defined by vaccination status at time of delivery: unvaccinated (n=48,492), unvaccinated propensity score matched (n=26,790), vaccinated (n=26,792; two doses of mRNA-1273 Moderna or BNT162b2 Pfizer-BioNTech), and\/or boosted (n=7,616). The primary outcome was maternal COVID-19 infection. COVID-19 vaccination status at delivery, COVID-19 infection-related health care, preterm birth (PTB), stillbirth, very low birth weight (VLBW), and small for gestational age (SGA) were evaluated as secondary outcomes.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Findings<\/jats:title>\n                  <jats:p>Vaccinated pregnant people were significantly less likely to have a maternal COVID-19 infection than unvaccinated matched (p&lt;0.0001) pregnant people. During a maternal COVID-19 infection, vaccinated pregnant people had similar rates of hospitalization (p=0.23), but lower rates of supplemental oxygen (p&lt;0.05) or vasopressor (p&lt;0.05) use than those in an unvaccinated matched cohort. Compared to an unvaccinated matched cohort, vaccinated people had significantly lower stillbirth rate (p&lt;0.01) as well as no difference in rate of PTB (p=0.35), SGA (p=0.79), or rate of VLBW (&gt;1,500 g; 0.31). Vaccinated people who were boosted had significantly lower rates of maternal COVID-19 infections (p&lt;0.0001), COVID-19 related hospitalization (p&lt;0.05), PTB (p&lt;0.05), stillbirth (p&lt;0.01), SGA (p&lt;0.05), and VLBW (p&lt;0.01), compared to vaccinated people that did not receive a third booster dose five months after completing the initial vaccination series.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Interpretation<\/jats:title>\n                  <jats:p>COVID-19 vaccination protects against adverse maternal-fetal outcomes with booster doses conferring additional protection against COVID-19 infection. It is therefore important for pregnant people to have high priority status for vaccination, and for them to stay current with their COVID-19 vaccination schedule.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Funding<\/jats:title>\n                  <jats:p>This study was funded by the National Institute for Child Health &amp; Human Development and the William O. and K. Carole Ellison Foundation.<\/jats:p>\n                <\/jats:sec>","DOI":"10.1101\/2022.08.12.22278727","type":"posted-content","created":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T12:40:17Z","timestamp":1660653617000},"source":"Crossref","is-referenced-by-count":6,"title":["The effect of COVID-19 vaccination and booster on maternal-fetal outcomes: a retrospective multicenter cohort study"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8119-6724","authenticated-orcid":false,"given":"Samantha N.","family":"Piekos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeon Mi","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan T.","family":"Roper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanya","family":"Sorensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan D.","family":"Price","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7158-3678","authenticated-orcid":false,"given":"Leroy","family":"Hood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6103-7606","authenticated-orcid":false,"given":"Jennifer J.","family":"Hadlock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2022082103250508000_2022.08.12.22278727v2.1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6938e1"},{"issue":"1","key":"2022082103250508000_2022.08.12.22278727v2.2","first-page":"75","article-title":"Higher severe acute respiratory syndrome coronavirus 2 infection rate in pregnant patients","volume":"225","year":"2021","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"2022082103250508000_2022.08.12.22278727v2.3","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1001\/jamapediatrics.2021.1050","article-title":"Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection: The INTERCOVID Multinational Cohort Study","volume":"175","year":"2021","journal-title":"JAMA Pediatr"},{"key":"2022082103250508000_2022.08.12.22278727v2.4","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6944e3"},{"key":"2022082103250508000_2022.08.12.22278727v2.5","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7047e1"},{"issue":"5","key":"2022082103250508000_2022.08.12.22278727v2.6","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1001\/jamainternmed.2020.9241","article-title":"Clinical Characteristics and Outcomes of Hospitalized Women Giving Birth With and Without COVID-19","volume":"181","year":"2021","journal-title":"JAMA Intern Med"},{"key":"2022082103250508000_2022.08.12.22278727v2.7","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000004339"},{"issue":"2","key":"2022082103250508000_2022.08.12.22278727v2.8","doi-asserted-by":"crossref","first-page":"e95","DOI":"10.1016\/S2589-7500(21)00250-8","article-title":"The effect of maternal SARS-CoV-2 infection timing on birth outcomes: a retrospective multicentre cohort study","volume":"4","year":"2022","journal-title":"Lancet Digit Health"},{"issue":"3","key":"2022082103250508000_2022.08.12.22278727v2.9","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/s41591-021-01666-2","article-title":"SARS-CoV-2 infection and COVID-19 vaccination rates in pregnant women in Scotland","volume":"28","year":"2022","journal-title":"Nat Med"},{"issue":"44","key":"2022082103250508000_2022.08.12.22278727v2.10","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.15585\/mmwr.mm6944e2","article-title":"Birth and Infant Outcomes Following Laboratory-Confirmed SARS-CoV-2 Infection in Pregnancy - SET-NET, 16 Jurisdictions, March 29-October 14, 2020","volume":"69","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"11","key":"2022082103250508000_2022.08.12.22278727v2.11","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1001\/jama.2021.2264","article-title":"Pregnant People\u2019s Paradox-Excluded From Vaccine Trials Despite Having a Higher Risk of COVID-19 Complications","volume":"325","year":"2021","journal-title":"JAMA"},{"key":"2022082103250508000_2022.08.12.22278727v2.12","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.13713"},{"key":"2022082103250508000_2022.08.12.22278727v2.13","doi-asserted-by":"publisher","DOI":"10.1055\/s-0041-1735878"},{"key":"2022082103250508000_2022.08.12.22278727v2.14","doi-asserted-by":"publisher","DOI":"10.2188\/jea.JE20210458"},{"issue":"3","key":"2022082103250508000_2022.08.12.22278727v2.15","doi-asserted-by":"crossref","first-page":"ofab433","DOI":"10.1093\/ofid\/ofab433","article-title":"Sources of Vaccine Hesitancy: Pregnancy, Infertility, Minority Concerns, and General Skepticism","volume":"9","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"2022082103250508000_2022.08.12.22278727v2.16","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-021-00728-6"},{"key":"2022082103250508000_2022.08.12.22278727v2.17","unstructured":"Centers for Disease Control and Prevention (CDC). COVID-19 vaccination among pregnant people aged 18-49 years overall, by race\/ethnicity, and date reported to CDC - Vaccine Safety Datalink, United States. Accessed July 6, 2022. https:\/\/covid.cdc.gov\/covid-data-tracker\/#vaccinations-pregnant-women"},{"key":"2022082103250508000_2022.08.12.22278727v2.18","doi-asserted-by":"publisher","DOI":"10.1172\/JCI153662"},{"key":"2022082103250508000_2022.08.12.22278727v2.19","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01490-8"},{"issue":"8","key":"2022082103250508000_2022.08.12.22278727v2.20","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1001\/jama.2021.11035","article-title":"Association Between BNT162b2 Vaccination and Incidence of SARS-CoV-2 Infection in Pregnant Women","volume":"326","year":"2021","journal-title":"JAMA"},{"key":"2022082103250508000_2022.08.12.22278727v2.21","doi-asserted-by":"publisher","DOI":"10.1101\/2021.02.03.21250579"},{"key":"2022082103250508000_2022.08.12.22278727v2.22","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000004367"},{"issue":"2","key":"2022082103250508000_2022.08.12.22278727v2.23","doi-asserted-by":"crossref","first-page":"402","DOI":"10.14336\/AD.2021.1210","article-title":"Clinical Characteristics, Transmissibility, Pathogenicity, Susceptible Populations, and Re-infectivity of Prominent COVID-19 Variants","volume":"13","year":"2022","journal-title":"Aging Dis"},{"issue":"2","key":"2022082103250508000_2022.08.12.22278727v2.24","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa2204399","article-title":"Maternal Vaccination and Risk of Hospitalization for Covid-19 among Infants","volume":"387","year":"2022","journal-title":"N Engl J Med"},{"key":"2022082103250508000_2022.08.12.22278727v2.25","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2022.0001"},{"key":"2022082103250508000_2022.08.12.22278727v2.26","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7101e1"},{"key":"2022082103250508000_2022.08.12.22278727v2.27","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.3271"},{"key":"2022082103250508000_2022.08.12.22278727v2.28","doi-asserted-by":"crossref","unstructured":"Kline A LY . PsmPy: A Package for Retrospective Cohort Matching in Python. In: 2022 44th Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC). ; 2022.","DOI":"10.1109\/EMBC48229.2022.9871333"},{"key":"2022082103250508000_2022.08.12.22278727v2.29","unstructured":"Cohen J. Quantitative methods in psychology: A power primer. In: Psychological Bulletin. ; 1992. Accessed July 31, 2022. https:\/\/citeseerx.ist.psu.edu\/viewdoc\/summary?doi=10.1.1.1043.9095"},{"key":"2022082103250508000_2022.08.12.22278727v2.30","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61602-X"},{"key":"2022082103250508000_2022.08.12.22278727v2.31","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7023a3"},{"key":"2022082103250508000_2022.08.12.22278727v2.32","unstructured":"Centers for Disease Control and Prevention (CDC). COVID Data Tracker: Variants & Genomic Surveillance: Variant Proportions. Accessed July 11, 2022. https:\/\/covid.cdc.gov\/covid-data-tracker\/#variant-proportions"},{"key":"2022082103250508000_2022.08.12.22278727v2.33","doi-asserted-by":"publisher","DOI":"10.15585\/MMWR.MM7013E3"},{"key":"2022082103250508000_2022.08.12.22278727v2.34","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.0470"},{"key":"2022082103250508000_2022.08.12.22278727v2.35","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2119451"},{"key":"2022082103250508000_2022.08.12.22278727v2.36","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMOA2114255\/SUPPL_FILE\/NEJMOA2114255_DISCLOSURES.PDF"},{"key":"2022082103250508000_2022.08.12.22278727v2.37","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7107e2"},{"key":"2022082103250508000_2022.08.12.22278727v2.38","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2021-069761"},{"issue":"18","key":"2022082103250508000_2022.08.12.22278727v2.39","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1056\/NEJMoa2201570","article-title":"Protection by a Fourth Dose of BNT162b2 against Omicron in Israel","volume":"386","year":"2022","journal-title":"N Engl J Med"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2022.08.12.22278727","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T14:48:32Z","timestamp":1768488512000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2022.08.12.22278727"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,16]]},"references-count":39,"URL":"https:\/\/doi.org\/10.1101\/2022.08.12.22278727","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1016\/S2589-7500(23)00093-6","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2022,8,16]]},"subtype":"preprint"}}